S Zobel-Roos,
A Schmidt, F Mestmäcker, M Mouellef… - Processes, 2019 - mdpi.com
Innovative biologics, including cell therapeutics, virus-like particles, exosomes, recombinant
proteins, and peptides, seem likely to substitute monoclonal antibodies as the main …